“This is welcome news. Dr. Makary was uniquely destructive to the prolife movement. He attempted to place pro-abortion lawyers in key positions. He slow walked a vitally necessary review of the abortion drug mifepristone. He used his discretion to approve a new abortion drug when the data shows it sends 1 in 10 women to the emergency room. He froze out prolife leaders and repeatedly stonewalled Congress. His resignation is an opportunity for the FDA to reset.
Back to stories
Trump Forces Out FDA Commissioner Marty Makary After 13 Months
May 12, 2026
FDA Commissioner Dr. Marty Makary resigned on May 12, 2026 after President Trump signed off on his ouster — ending a turbulent 13-month tenure marked by conflicts with the White House, anti-abortion groups, and the vaping industry. Makary was caught in crossfire from multiple directions: Trump was furious that Makary tried to block FDA approval of fruit-flavored e-cigarettes, citing their appeal to children. Anti-abortion groups including Susan B. Anthony Pro-Life America demanded his removal for slow-walking a safety review of the abortion pill mifepristone. Pharmaceutical industry allies were also critical of his leadership style. Trump praised Makary as a "wonderful man" who would "lead a good life." Kyle Diamantas, the FDA's Deputy Commissioner for Food, was named acting FDA chief pending a permanent replacement requiring Senate confirmation. Democrats praised Makary as someone who resisted White House pressure on vaping, while several Republican senators — unhappy about the mifepristone delay — welcomed his departure and called for a more explicitly pro-life successor.
3
Statements Recorded
See what your representatives said?
3 Statements
“I voted for Dr. Makary to head the FDA based upon his commitment to say 'no' if President Trump asked him to do something that would harm America. Dr. Makary kept his word. He resisted Trump's plan to expose millions of children to the dangers of vaping. I hope Dr. Makary will inspire others within the Trump Administration to grow a spine and put the families of America ahead of blind loyalty to this President.
“Dr. Makary was part of a broader symptom of an administration that has not paid attention to pro-life issues. I care deeply about life, and I anticipate the next FDA nominee shall as well.